Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI

Published: 01 September 2020

  • Views:

    Views Icon 1422
  • Likes:

    Heart Icon 1

Overview

Full programme

  • Views:

    Views Icon 1422
  • Likes:

    Heart Icon 1

Overview

In this series of videos Kurt Huber, Davide Capodanno, Stefan James and Roxana Mehran discuss Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI

Supported by an unrestricted educational grant from AstraZeneca

Learning Objectives

  • Review the clinical landscape for antiplatelet therapy in patients with ACS.
  • Discuss recent data on DAPT for patients with ACS
  • Provide expert insight on application in routine clinical practice

Series overview

Part 1

Welcome

1 session
Welcome Watch now

Part 2

Pre-treatment in NSTE-ACS – Dead or Alive?

Part 3

Choice of Antithrombotic Agent in ACS: REACT-ing to Recent Trials

Part 4

When to leave Aspirin behind?

Part 5

Q&As

1 session
Q&As Watch now

Faculty Biographies

Kurt Huber

Kurt Huber

Director of the 3rd Department of Medicine, Cardiology and Emergency Medicine, Wilhelmeinenhospital, Vienna, Austria

View full profile